Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 189

1.

Patterns of health care utilization related to initiation of amitriptyline, duloxetine, gabapentin, or pregabalin in fibromyalgia.

Kim SC, Landon JE, Lee YC.

Arthritis Res Ther. 2015 Jan 28;17:18. doi: 10.1186/s13075-015-0530-8.

2.
3.

Cost effectiveness of pregabalin in the treatment of fibromyalgia from a UK perspective.

Choy E, Richards S, Bowrin K, Watson P, Lloyd A, Sadosky A, Zlateva G.

Curr Med Res Opin. 2010 Apr;26(4):965-75. doi: 10.1185/03007991003600271.

PMID:
20178405
4.

Direct medical costs and medication compliance among fibromyalgia patients: duloxetine initiators vs. pregabalin initiators.

Sun P, Peng X, Sun S, Novick D, Faries DE, Andrews JS, Wohlreich MM, Wu A.

Pain Pract. 2014 Jan;14(1):22-31. doi: 10.1111/papr.12044. Epub 2013 Mar 14.

PMID:
23489659
5.

Real-world comparison of health care utilization between duloxetine and pregabalin initiators with fibromyalgia.

Peng X, Sun P, Novick D, Andrews J, Sun S.

J Pain Res. 2014 Jan 9;7:37-46. doi: 10.2147/JPR.S51636. eCollection 2014.

6.

Potential drug-drug and drug-condition interactions among fibromyalgia patients initiating pregabalin or duloxetine: prevalence and health care expenditure impact.

Johnston SS, Udall M, Cappelleri JC, Johnson BH, Shrady G, Chu BC, Silverman SL.

Pain Med. 2014 Aug;15(8):1282-93. doi: 10.1111/pme.12330. Epub 2014 Jan 8.

PMID:
24401017
7.

Healthcare Costs and Medication Adherence Among Patients with Fibromyalgia: Combination Medication vs. Duloxetine, Milnacipran, Venlafaxine, and Pregabalin Initiators.

Marlow NM, Simpson KN, Vaughn IA, Jo A, Zoller JS, Short EB.

Pain Pract. 2018 Feb;18(2):154-169. doi: 10.1111/papr.12585. Epub 2017 May 28.

8.

Treatment Patterns Associated with ACR-Recommended Medications in the Management of Fibromyalgia in the United States.

Liu Y, Qian C, Yang M.

J Manag Care Spec Pharm. 2016 Mar;22(3):263-71. doi: 10.18553/jmcp.2016.22.3.263.

9.

Comparison of medication adherence and healthcare costs between duloxetine and pregabalin initiators among patients with fibromyalgia.

Zhao Y, Sun P, Watson P, Mitchell B, Swindle R.

Pain Pract. 2011 May-Jun;11(3):204-16. doi: 10.1111/j.1533-2500.2010.00412.x. Epub 2010 Aug 27.

PMID:
20807351
10.

Comparative safety and tolerability of duloxetine vs. pregabalin vs. duloxetine plus gabapentin in patients with diabetic peripheral neuropathic pain.

Irving G, Tanenberg RJ, Raskin J, Risser RC, Malcolm S.

Int J Clin Pract. 2014 Sep;68(9):1130-40. doi: 10.1111/ijcp.12452. Epub 2014 May 18.

PMID:
24837444
11.

Real-world evaluation of health-care resource utilization and costs in employees with fibromyalgia treated with pregabalin or duloxetine.

Harnett J, Margolis J, Cao Z, Fowler R, Sanchez RJ, Mardekian J, Silverman SL.

Pain Pract. 2011 May-Jun;11(3):217-29. doi: 10.1111/j.1533-2500.2010.00440.x. Epub 2010 Dec 28.

PMID:
21199319
12.

A systematic review of pharmacoeconomic studies for pregabalin.

Parker L, Huelin R, Khankhel Z, Wasiak R, Mould J.

Pain Pract. 2015 Jan;15(1):82-94. doi: 10.1111/papr.12193. Epub 2014 May 10. Review.

PMID:
24815038
13.

Clinical characteristics, pharmacotherapy and healthcare resource use among patients with fibromyalgia newly prescribed gabapentin or pregabalin.

Gore M, Sadosky AB, Zlateva G, Clauw DJ.

Pain Pract. 2009 Sep-Oct;9(5):363-74. doi: 10.1111/j.1533-2500.2009.00292.x. Epub 2009 Jun 4.

14.

Comparative efficacy and safety of six antidepressants and anticonvulsants in painful diabetic neuropathy: a network meta-analysis.

Rudroju N, Bansal D, Talakokkula ST, Gudala K, Hota D, Bhansali A, Ghai B.

Pain Physician. 2013 Nov-Dec;16(6):E705-14. Erratum in: Pain Physician. 2014 Mar-Apr;17(2):203.

15.

Medication dosing patterns associated with duloxetine and pregabalin among patients with fibromyalgia.

Sun P, Zhao Y, Zhao Z, Watson P.

Curr Med Res Opin. 2011 Sep;27(9):1793-801. doi: 10.1185/03007995.2011.605113. Epub 2011 Aug 3.

PMID:
21810060
16.

Cost-effectiveness analysis of pharmacologic treatment of fibromyalgia in Mexico.

Arreola Ornelas H, Rosado Buzzo A, García L, Dorantes Aguilar J, Contreras Hernández I, Mould Quevedo JF.

Reumatol Clin. 2012 May-Jun;8(3):120-7. doi: 10.1016/j.reuma.2011.12.009. Epub 2012 Mar 3.

17.
18.

Identification of patients with painful diabetic peripheral neuropathy who have a favorable cost profile with pregabalin treatment.

Udall M, Mardekian J, Cabrera J.

Pain Pract. 2013 Jul;13(6):476-84. doi: 10.1111/papr.12008. Epub 2012 Nov 14.

PMID:
23150918
19.

Clinical characteristics, pharmacotherapy, and healthcare resource use among patients with diabetic neuropathy newly prescribed pregabalin or gabapentin.

Gore M, Tai KS, Zlateva G, Bala Chandran A, Leslie D.

Pain Pract. 2011 Nov-Dec;11(6):528-39. doi: 10.1111/j.1533-2500.2011.00450.x. Epub 2011 Mar 16.

PMID:
21435162
20.

Suboptimal Treatment of Diabetic Peripheral Neuropathic Pain in the United States.

Yang M, Qian C, Liu Y.

Pain Med. 2015 Nov;16(11):2075-83. doi: 10.1111/pme.12845. Epub 2015 Jun 27.

PMID:
26118704

Supplemental Content

Support Center